BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 33709632)

  • 1. Comparison of
    Yu HN; Liu L; Chen QS; He Q; Li YS; Wang Y; Gao S
    Orthop Surg; 2021 May; 13(3):791-798. PubMed ID: 33709632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of 18F-AlF-NOTA-Octreotide PET/CT in the Localization of Tumor-Induced Osteomalacia.
    Long T; Hou J; Yang N; Zhou M; Li Y; Li J; Tang Y; Chen D; Hu S
    J Clin Endocrinol Metab; 2021 Sep; 106(10):e4202-e4209. PubMed ID: 33864458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of 18F-FDG and 68Ga DOTATATE PET/CT in localization of tumor causing oncogenic osteomalacia.
    Agrawal K; Bhadada S; Mittal BR; Shukla J; Sood A; Bhattacharya A; Bhansali A
    Clin Nucl Med; 2015 Jan; 40(1):e6-e10. PubMed ID: 24999675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 68Ga DOTATATE PET/CT is an Accurate Imaging Modality in the Detection of Culprit Tumors Causing Osteomalacia.
    Zhang J; Zhu Z; Zhong D; Dang Y; Xing H; Du Y; Jing H; Qiao Z; Xing X; Zhuang H; Li F
    Clin Nucl Med; 2015 Aug; 40(8):642-6. PubMed ID: 26053726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sporadic Primary Pheochromocytoma: A Prospective Intraindividual Comparison of Six Imaging Tests (CT, MRI, and PET/CT Using
    Jha A; Patel M; Carrasquillo JA; Ling A; Millo C; Saboury B; Chen CC; Wakim P; Gonzales MK; Meuter L; Knue M; Talvacchio S; Herscovitch P; Rivero JD; Chen AP; Nilubol N; Taïeb D; Lin FI; Civelek AC; Pacak K
    AJR Am J Roentgenol; 2022 Feb; 218(2):342-350. PubMed ID: 34431366
    [No Abstract]   [Full Text] [Related]  

  • 7. Functional imaging of neuroendocrine tumors with combined PET/CT using 68Ga-DOTATATE (DOTA-DPhe1,Tyr3-octreotate) and 18F-FDG.
    Kayani I; Bomanji JB; Groves A; Conway G; Gacinovic S; Win T; Dickson J; Caplin M; Ell PJ
    Cancer; 2008 Jun; 112(11):2447-55. PubMed ID: 18383518
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    El-Maouche D; Sadowski SM; Papadakis GZ; Guthrie L; Cottle-Delisle C; Merkel R; Millo C; Chen CC; Kebebew E; Collins MT
    J Clin Endocrinol Metab; 2016 Oct; 101(10):3575-3581. PubMed ID: 27533306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic efficiency of
    He Q; Zhang B; Zhang L; Chen Z; Shi X; Yi C; Wang X; Zhang X
    Eur Radiol; 2021 Apr; 31(4):2414-2421. PubMed ID: 33021702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of
    Lee DY; Lee SH; Kim BJ; Kim W; Yoon PW; Lee SJ; Oh SJ; Koh JM; Ryu JS
    Sci Rep; 2021 Jan; 11(1):1819. PubMed ID: 33469091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Activity Due to Fractures Does Not Significantly Affect the Accuracy of 68Ga-DOTATATE PET/CT in the Detection of Culprit Tumor in the Evaluation of Tumor-Induced Osteomalacia.
    Ding J; Hu G; Wang L; Li F; Huo L
    Clin Nucl Med; 2018 Dec; 43(12):880-886. PubMed ID: 30273206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic performance of
    Kato A; Nakamoto Y; Ishimori T; Hayakawa N; Ueda M; Temma T; Sano K; Shimizu Y; Saga T; Togashi K
    Ann Nucl Med; 2021 Mar; 35(3):397-405. PubMed ID: 33582980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MIB-1 Index-Stratified Assessment of Dual-Tracer PET/CT with
    Sampathirao N; Basu S
    J Nucl Med Technol; 2017 Mar; 45(1):34-41. PubMed ID: 28154019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The utility of
    Jaiswal SK; Sarathi V; Malhotra G; Hira P; Shah R; Patil VA; Dalvi A; Prakash G; Lila AR; Shah NS; Bandgar T
    J Pediatr Endocrinol Metab; 2021 Jan; 34(1):109-119. PubMed ID: 33180042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of
    Şahin OE; Uslu-Beşli L; Asa S; Sağer S; Sönmezoğlu K
    Hell J Nucl Med; 2020; 23(3):321-329. PubMed ID: 33367304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of
    Zhang S; Wang L; Wang T; Xing HQ; Huo L; Li F
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Dec; 40(6):757-764. PubMed ID: 30606385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of 177Lu-DOTATATE-based peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumor: a multiparametric response evaluation correlating with primary tumor site, tumor proliferation index, and dual tracer imaging characteristics.
    Thapa P; Ranade R; Ostwal V; Shrikhande SV; Goel M; Basu S
    Nucl Med Commun; 2016 Oct; 37(10):1030-7. PubMed ID: 27243215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of (18F)FDG PET/CT and (68Ga)DOTATATE PET/CT imaging methods in terms of detection of histological subtype and related SUVmax values in patients with pulmonary carcinoid tumors.
    Komek H; Can C; Urakçi Z; Kepenek F
    Nucl Med Commun; 2019 May; 40(5):517-524. PubMed ID: 30694875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving diagnosis of tumor-induced osteomalacia with Gallium-68 DOTATATE PET/CT.
    Clifton-Bligh RJ; Hofman MS; Duncan E; Sim IeW; Darnell D; Clarkson A; Wong T; Walsh JP; Gill AJ; Ebeling PR; Hicks RJ
    J Clin Endocrinol Metab; 2013 Feb; 98(2):687-94. PubMed ID: 23295468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. False-Positive
    Parghane RV; Basu S
    J Nucl Med Technol; 2023 Mar; 51(1):73-74. PubMed ID: 35197273
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 26.